HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL

McNerney, K. O., Si Lim, S. J., Ishikawa, K., Dreyzin, A., Vatsayan, A., Chen, J. J., Baggott, C., Prabhu, S., Pacenta, H. L., Philips, C., Rossoff, J., Stefanski, H. E., Talano, J.-A., Moskop, A., Verneris, M., Myers, D., Karras, N. A., Brown, P., Bonifant, C. L., … Schultz, L. M. (2023). HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL. Blood Advances, 7(12), 2758–2771. https://doi.org/10.1182/bloodadvances.2022008893
Authors:
Kevin O. McNerney
Stephanie J. Si Lim
Kyle Ishikawa
Alexandra Dreyzin
Anant Vatsayan
Kevin Cassel
Christina Baggott
Snehit Prabhu
Holly Pacenta
Christine Philips
Jenna Rossoff
Heather E. Stefanski
Julie-An Talano
Amy Moskop
Michael R. Verneris
Doug Myers
Nicole Karras
Patrick A. Brown
Challice L. Bonifant
Muna Qayed
Michelle L. Hermiston
Prakash Satwani
Christa Krupski
Amy K. Keating
Susanne H.C. Baumeister
Vanessa A. Fabrizio
Vasant Chinnabhandar
Emily Egeler
Sharon Mavroukakis
Kevin J. Curran
Crystal L. Mackall
Theodore W. Laetsch
Liora M. Schultz
Affiliated Authors:
Prakash Satwani
Columbia Affiliation:
Subjects:
Lymphohistiocytosis, Hemophagocytic (MeSH)
Receptors, Chimeric Antigen (MeSH)
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (MeSH)
Burkitt Lymphoma (MeSH)
Hemophagocytic Lymphohistiocytosis and Related Disorders (OpenAlex Topic)
Epidemiology and Treatment of Childhood Leukemia (OpenAlex Topic)
Natural Killer Cells in Immunity (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/bloodadvances.2022008893
PMID:
36857419
DOI:
10.1182/bloodadvances.2022008893
Journal:
Blood Advances
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record

Record Created: